Skip to main content
. 2020 Jul 7;4(9):bvaa093. doi: 10.1210/jendso/bvaa093

Figure 1.

Figure 1.

Effect of IL-6 receptor blockade (with tocilizumab) on CTX and P1NP during an acute exercise bout and a post exercise meal. Measurements during an acute exercise bout (time point 0-60 min) and a postexercise MMTT (time point 60-180 min) with and without IL-6 receptor blockade (with tocilizumab) on (A) plasma CTX and (C) plasma P1NP concentrations. (B) Plasma CTX and (D) plasma P1NP concentrations expressed as percentage change from baseline (time point 0). Data represent mean values; error bars indicate SEM. N = 5. Filled circles placebo (saline), open circles IL-6 receptor blockade (with tocilizumab).